ÌÇÐÄÆƽâ°æ

In 2025, Johnson & Johnson's sales in the United States came to over ** billion U.S. dollars. Thus, the largest part of the company’s revenue was generated in the United States. Europe is the company's second most yielding region, with some ** billion U.S. dollars in sales. Johnson & Johnson is a U.S.-based multinational company, specializing in pharmaceuticals and medical technology. The company is headquartered in New Brunswick, New Jersey. 

Johnson & Johnson’s global positioning

Johnson & Johnson was among the top pharmaceutical companies globally in recent years. Based on prescription sales and research and development spending, Johnson & Johnson was ranked first in prescription sales and second in spending on research and development. In terms of the research and development pipeline, Johnson & Johnson ranked among the top seven pharmaceutical companies worldwide as of 2025. 

Research and development at Johnson & Johnson

Johnson & Johnson’s expenditures on research and development, like their revenue, have been increasing recently. When viewed as a percentage of revenue, research and development spending has only increased significantly in 2024, to over ** billion U.S. dollars.